The bar for resistance with mona perever, the cove pill, is rather high. The drug works by inducing errors into the corono viruss genetic material. Those errors are then replicated until the virus is practically desumd. This means that the virus has fewer opportunities to develop those mutin forms that will overcome those errors.
Peter Quigley, President and CEO of Kelly, discusses the jobs September report and employment trends. Bloomberg News U.S. Health Care Reporter Riley Griffin explains how Merck’s Covid pill faces a risk that the virus could outsmart it. Bloomberg News Financial Investigations Reporter Caleb Melby shares his Businessweek Magazine story New York’s Real Estate Tax Breaks Are Now a Rich-Kid Loophole. Dartmouth Professor of Economics Danny Blanchflower talks about seeing a U.S. recession if the history of consumer sentiment repeats. Eric Ervin, CIO at Onramp Invest, breaks down understanding and owning cryptocurrencies. And we Drive to the Close with Alan Lancz, Research Director at www.LanczGlobal.com.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.